Dental Care Clinics in Turners Falls, MA Accepting Medicare
5 Dental Care Clinics found. Showing 1 - 5
 James A Andreas Dmd Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 7 Burnham Street, Turners Falls, MA 01376 Phone: 413-774-6553 Fax: 413-773-9502 |
Montague Dental Arts Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 300 Avenue A, Turners Falls, MA 01376 Phone: 860-990-4377 |
Avenue A Dental Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 173 Avenue A, Turners Falls, MA 01376 Phone: 413-863-2296 Fax: 413-863-2298 |
Daniel Cohen, Dmd, Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 4 Dell St, Turners Falls, MA 01376 Phone: 413-863-9656 Fax: 413-863-2946 |
Jeffrey M. Collura, Dmd, Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 7 Burnham St, Turners Falls, MA 01376 Phone: 413-774-6553 Fax: 413-773-9502 |
News Archive
Bayer presents results from Phase III ROCKET AF trial for atrial fibrillation at American Heart Association
Bayer today announced the results from the pivotal, double-blind Phase III, ROCKET AF trial. In the study, rivaroxaban demonstrated superiority to warfarin in reducing the risk of stroke and non-CNS systemic embolism in patients with atrial fibrillation (AF).
Penn-ICOWHI conference to examine how urban environments affect women's health
Women comprise more than half the population of the nation's cities, are three times as likely as their male counterparts to live alone after the age of 65, and are primary caregivers for their families at all ages and stages of life. The University of Pennsylvania School of Nursing, with the International Congress of Women's Health Issues, will host "Cities and Women's Health: Global Perspectives," Wednesday, April 7, through Saturday, April 10, on Penn's campus to examine how urban environments affect their health.
Liquidia Technologies completes $20M Series C financing round
Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, today announced it has completed a $20 million round of Series C financing. Canaan Partners led the Series C round, which also included Pappas Ventures and Morningside Venture Investments Limited as new investors. Previous investors, including New Enterprise Associates and Firelake Capital, also participated in the financing round.
EU research project is studying the effect of endocrine disruptors on metabolism
January 2019 saw the launch of the EU research project EDCMET, in which scientists from the German Federal Institute for Risk Assessment (BfR) are also involved.
Positive clinical data of AVEO's tivozanib featured at 2011 ASCO Genitourinary Cancers Symposium
AVEO Pharmaceuticals, Inc. today announced that previously reported positive clinical data evaluating tivozanib, its lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, in patients with renal cell carcinoma (RCC) will be featured in several poster presentations at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17-19, 2011 at the Orlando World Center Marriott in Orlando, Fla.
› Verified 7 days ago